Trial Profile
New antipsychotic strategies: quetiapine and risperidone vs. fluphenazine in treatment resistant schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Risperidone (Primary) ; Fluphenazine
- Indications Schizophrenia
- Focus Therapeutic Use
- 05 Nov 2008 Status changed from active, no longer recruiting to completed.
- 04 Dec 2005 New trial record.